An immunogold single extracellular vesicular RNA and protein ((Au)SERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients

Conventional PD‐L1 immunohistochemical tissue biopsies only predict 20%–40% of non‐small cell lung cancer (NSCLC) patients that will respond positively to anti‐PD‐1/PD‐L1 immunotherapy. Herein, we present an immunogold biochip to quantify single extracellular vesicular RNA and protein ((Au)SERP) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Luong T. H., Zhang, Jingjing, Rima, Xilal Y., Wang, Xinyu, Kwak, Kwang Joo, Okimoto, Tamio, Amann, Joseph, Yoon, Min Jin, Shukuya, Takehito, Chiang, Chi‐Ling, Walters, Nicole, Ma, Yifan, Belcher, Donald, Li, Hong, Palmer, Andre F., Carbone, David P., Lee, L. James, Reátegui, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465631/
https://www.ncbi.nlm.nih.gov/pubmed/36093740
http://dx.doi.org/10.1002/jev2.12258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465631/
https://www.ncbi.nlm.nih.gov/pubmed/36093740
http://dx.doi.org/10.1002/jev2.12258

Ejemplares similares